Health
Johnson & Johnson COVID-19 vaccine candidate demonstrates robust protection in pre-clinical studies – manilastandard.net
Johnson Johnson announced that its lead vaccine candidate for COVID-19 elicited a robust immune response as demonstrated by neutralizing antibodies in pre-clinical studies.
6th Floor Universal Re Bldg., 106 Paseo De Roxas cor. Perea Street, Legaspi Village, 1226 Makati City Philippines
Trunklines: 832-5554, 832-5556, 832-5558…
Continue Reading
-
Noosa News8 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News9 hours agoMotorcyclist dies in crash with truck
-
Noosa News24 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial
-
General24 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate